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Pregnancy Outcomes in Pre-gestational and Gestational
Diabetic Women in Comparison to Non-diabetic
Women – A Prospective Study in Asian Indian Mothers
(CURES-35)
AK Shefali*, M Kavitha**, R Deepa*, V Mohan*
Abstract
Background and objective : Diabetes can complicate pregnancy but it is not the major complication of pregnancy.
Though prevalence of diabetes is alarmingly high among Indians there have been very few studies assessing
the effect of diabetes on pregnancy outcomes, particularly comparing pre-gestational diabetes mellitus [PGDM]
and gestational diabetes [GDM] with non-diabetic mothers.
Methods : Pregnant women attending the Dr. Mohan's Diabetes Specialities Centre, a tertiary care centre for
diabetes in Chennai in southern India were selected for the study. PGDM and GDM were defined using
standard criteria.  Out of the 245 pregnant women with diabetes registered at the centre, follow up data was
available for 225, which included 79 PGDM and 146 GDM subjects. Non-diabetic controls (n=30) were
recruited from the ongoing population based study the Chennai Urban Rural Epidemiology Study (CURES).
Details of outcome variables including abortions, mode of delivery, congenital anomalies and neonate’s birth
weight were documented.
Results : Women with PGDM had significantly higher fasting plasma glucose [p<0.001] and fructosamine
[p<0.001] levels compared to GDM. Proportion of women who underwent abortions was 0% in non-diabetic
controls, 10.1% in PGDM and 2.7% in GDM and the difference between PGDM and GDM was statistically
significant [p = 0.04]. Prevalence of ‘low birth weight’ babies in the study groups were, 14.3% in non-diabetic
mothers, 12.3% in PGDM and 8.2% in GDM. The prevalence of ‘large babies’ was higher in GDM [27.6%] and
PGDM [19.2%] groups compared to non-diabetic controls [7.1%] but the differences reached statistical
significance only in the GDM group [p = 0.04].  Prevalence of congenital anomalies was 0% among non-
diabetic controls, 3.8% in PGDM and 1.4% in GDM but the differences did not reach statistical significance.
A significant increase in frequency of abortions [trend chi square = 5.67, p = 0.017] and ‘low birth weight’
babies [trend chi square = 4.761,p = 0.029] was observed with increasing fructosamine levels in the diabetic
mothers.
Conclusion : Women with diabetes have worse pregnancy outcomes compared to non-diabetic mothers with
and those with pre-gestational diabetes fare worse than those with gestational diabetes. The study emphasizes
the fact that strict glycemic control is extremely important during pregnancy.  ©
Diabetes complicates between 1-20% of allpregnancies worldwide, which includes pre-
gestational diabetes mellitus (PGDM – also referred to
as diabetes complicating pregnancy) and gestational
diabetes mellitus (GDM).1 There are several studies in
the west demonstrating that diabetes during pregnancy
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is associated with a number of adverse effects on the
mother and the neonate.2-4 Ethnic differences have been
demonstrated not only in the prevalence of PGDM and
GDM but also with respect to the outcomes of the
pregnancy.2,3 Migrant Indians who are well known to
have a greater predisposition to diabetes compared to
Europeans have also been shown to have a higher
prevalence of diabetes during pregnancy.4 However there
are  only  a  few  Indian  studies  on diabetes in
pregnancy.5 -8 This is of interest given that India has the
largest number of diabetic patients in the world with
31.4 million diabetic subjects in the year 2000.8,9 Further,
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it is estimated that nearly 2.5 million women in the
reproductive age [20-44 years] are affected by diabetes.10
This translates to a huge number of PGDM and probably
even higher number of GDM. In this context, data on the
outcomes of pregnancies in Indian diabetic women
(PGDM and GDM) is very important.
Participants and Design
All pregnant women attending the Dr. Mohan's
Diabetes Specialities Centre, a tertiary care centre for
diabetes in Chennai in southern India during the period
of 2000- 2003 were recruited for the study. GDM was
defined as any degree of glucose intolerance with its
first recognition during pregnancy. Patients with onset
of diabetes prior to their last menstrual period were
assigned to the PGDM group and this included patients
with Type 2 diabetes, Type 1 diabetes and other
secondary forms of diabetes like Fibrocalculous
Pancreatic Diabetes (FCPD).
Of a consecutive series of 245 pregnant women with
diabetes registered at the centre, follow up data was
available in 225, which included 79 PGDM and 146
GDM subjects.
Non-responders
There were no significant differences in the baseline
clinical and biochemical profile of the 225 ‘responders’
and the 20 ‘non-responders’ [Responders vs non-
responders, age: 29 ± 5 years vs 27 ± 7 years, p=0.23;
fructosamine: 158 ± 63 µmol/l vs 149 ± 43  µmol/l,
p=0.53; HbA1c: 8.2 ± 1.9% vs 8.1 ± 1.2%, p=0.82].
Control population
Non-diabetic pregnant women (n = 30) were recruited
from our large population based study, the Chennai
Urban Rural Epidemiology Study (CURES), an ongoing
epidemiological study conducted on a representative
population (aged ≥  20 years) of Chennai. The
methodology of the study has been published
elsewhere.11 Briefly, in Phase 1 of CURES, 26,001
individuals were recruited based on a systematic
random sampling technique. Self reported diabetic
subjects on drug treatment of diabetes were classified as
‘known diabetic subjects’. Fasting capillary blood
glucose was determined in all subjects using a One Touch
Basic glucometer (Lifescan, Milpitas, California, USA).
In Phase 2 of CURES, all the known diabetic subjects
(n=1529) were invited to the centre for detailed studies.
In addition, age and sex matched non-diabetic subjects
(fasting capillary blood glucose<100 mg/dl) and all
subjects with fasting capillary blood glucose ≥ 110 mg/
dl based on ADA fasting criteria,12 underwent oral
glucose tolerance tests (OGTT) using 75 gms oral glucose
load dissolved in 250ml of water.  Those who were
confirmed by OGTT to have 2hr post load plasma glucose
value ≥ 200 mg/dl based on WHO consulting group
criteria13  were labelled as ‘newly detected diabetic
subjects’.  Subjects who had fasting plasma glucose  <100
mg/dl and 2hr plasma glucose value <140 mg/dl were
categorized as normal glucose tolerance (NGT). We
identified 30 women with NGT who were in the first or
second trimester of pregnancy during phase 1 of CURES
and did not develop diabetes thereafter during
pregnancy (medical records were scrutinized).
Pregnancy outcome variables were studied in these 30
subjects.
Patient evaluation
Details on the medical history, family history of
diabetes and obstetric history were collected using a
proforma. All the study subjects underwent a complete
physical examination and biochemical assessment was
done. Sitting blood pressure was recorded to the nearest
2 mm of Hg using a standard mercury
sphygmomanometer (Diamond Deluxe BP Apparatus,
Pune, India).
A fasting blood sample was taken for biochemical
estimation. Biochemical analyses were carried out on
Hitachi - 912 Autoanalyser (Hitachi, Germany) using
kits supplied by Roche Diagnostics, (Mannheim,
Germany). Fasting plasma glucose (GOD - POD method),
fructosamine (NBT method), serum cholesterol (CHOD-
PAP method), serum triglycerides (GPO-PAP method)
and HDL cholesterol (Direct method – polyethylene
glycol-pretreated enzymes) were measured.  Glycated
haemoglobin (HbA1C) was estimated by high-pressure
liquid chromatography using the Variant machine (Bio-
Rad, Hercules, Calif., USA).
For the non-diabetic controls, from CURES,
fructosamine and HbA1c assays were not performed.
Diagnosis of diabetes
Diagnosis of GDM was done using American
Diabetes Association (ADA) (NDDG revised criteria of
O’Sullivan and Mahan criteria).12  Diagnosis of diabetes
was accepted in the PGDM group if they were on drug
treatment for diabetes or had diabetes according to World
Health Organization (WHO) 1998 criteria.13
Outcome measures :  Data regarding neonate’s birth
weight were obtained from the mother or from hospital
discharge summaries. They were classified as ‘large
babies’ if the birth weight was > 3.5 kg and ‘low birth
weight’ if birth weight was < 2.5 kg, only for those who
had  a full-term delivery.
Details were also collected regarding abortions and
mode of delivery. The latter was classified as assisted if
it was a cessarean section, vacuum assisted or a forceps
assisted delivery. Congenital anomalies, if any, were
documented.
Statistical analysis
One-way ANOVA or students “t” test as appropriate
was used to compare groups for continuous variables.
Chi-square test or Fisher’s Exact test as appropriate was
used to compare proportions. All analysis was done
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using Windows based SPSS statistical package (Version
10.0, Chicago) and p values <0.05 were taken as
significant.
RESULTS
Of the 79 PGDM’s, 73(92.4%) were recruited in first
trimester and the rest were recruited in the second
trimester. Among the GDMs 28(19.0%)were recruited in
first trimester, 85(58.2%) in second trimester and
33(22.6%) in third trimester.
Characteristics of the study population : Table 1
presents the characteristics of the study groups. Non-
diabetic mothers had lower blood pressures compared
to diabetic mothers(p<0.01). There was no significant
difference in the mean age between the study groups.
Fasting plasma glucose [p<0.001] and fructosamine
[p<0.001] levels were significantly higher among PGDM
compared to GDM. Though the HbA1c values were
higher in PGDM, the difference did not reach statistical
significance.
Treatment : The PGDM group required intensive
therapy and 20 subjects (25.3%) were on multiple insulin
regimens, 43(54.4%) on twice daily insulins and the rest
were on single dose of insulin injections. Among the
GDM group only 47.2% (69/146) were on insulin
injections while the rest were treated with diet alone.
Pregnancy outcomes : Table 2 compares the pregnancy
outcomes in the study groups. Proportion of women who
underwent abortions was 0% in non-diabetic controls,
10.1% in PGDM and 2.7% in GDM and the difference
between PGDM and GDM was statistically significant
[p = 0.04]. Assisted deliveries were significantly higher
among diabetic mothers compared to non-diabetic
controls (PGDM  : 60.8%, GDM : 59.6%, Non-diabetic
subjects : 20.0%, p < 0.001).
There were 2 (6.7%) preterm deliveries in non-diabetic
controls, 6(7.6%) in PGDM and 12(8.2%) in GDM and
these subjects were excluded from the analysis on birth
weight of neonates.
Prevalence of ‘low birth weight’ babies in the study
groups were, 14.3% in non-diabetic mothers, 12.3% in
PGDM and 8.2% in GDM and the differences did not
reach statistical significance. The prevalence of ‘large
babies’ was significantly higher in GDM compared to
non-diabetic controls [27.6% vs 7.1%, p = 0.04]. Though
the prevalence of large babies was higher among the
PGDM [19.2%] compared to non-diabetic controls, the
difference did not reach statistical significance.
Prevalence of congenital anomalies was 0% among
non-diabetic controls,  3.8% in PGDM and 1.4% in GDM
and the differences did not reach statistical significance.
Table 1 : Clinical characteristics of the study groups
Parameters Non-diabetic Pre-gestational Gestational diabetes
subjects (n = 30)  diabetes mellitus (n = 79)  mellitus (n = 146)
Family history of diabetes n (%) 0 64 (81.0%)** 121 (82.3)**
Age (years) 28 ± 4 29 ± 6 29 ± 5
Systolic blood pressure (mm Hg) 109 ± 12 118 ± 10** 119 ± 12**
Diastolic blood pressure (mm Hg) 73 ± 7 78 ± 8* 77 ± 7*
Fasting plasma glucose (mg/dl)
Baseline 88 ± 11 149 ± 58** 109 ± 35**##
Third trimester — 116 ± 45 103 ± 45#
Fructosamine (µmol/l)
Baseline — 299 ± 100 225 ± 50##
Third trimester — 218 ± 33 202 ± 30#
HbA1c (%)
Baseline — 7.1 ± 1.6 6.8 ± 1.7
Third trimester — 6.5 ± 1.5 6.2 ± 1.3
*p < 0.01 compared to non-diabetic subjects. **p < 0.001 compared to non-diabetic subjects. #p<0.05 compared to PGDM.
##p<0.001 compared to PGDM. Family history of diabetes was considered positive if either father or mother had diabetes.
Table 2 : Pregnancy outcomes in the study groups
Parameters Non-diabetic Pre-gestational Gestational diabetes
subjects (n = 30)  diabetes mellitus (n = 79)  mellitus (n = 146)
Abortions n (%) 0 8 (10.1)# 4 (2.7)
Assisted n (%) 6 (20.0) 48 (60.8)** 87 (59.6)**
Congenital anomalies n (%) 0% 3 (3.8) 2 (1.4)
Birth weight (n = 28) (n = 73) (n = 134)
Low birth weight n (%) 4 (14.3) 9 (12.3) 11 (8.2)
Large babies n (%) 2 (7.1) 14 (19.2) 37 (27.6)*
*p =0.04 compared to non-diabetic subjects. **p < 0.001 compared to non-diabetic subjects. #p=0.04 compared to gestational
diabetes mellitus.
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Proportion of abortions and low birth weight was
computed according to levels of fructosamine only in
the diabetic women. Fig. 1 shows a significant increase
in the proportion of abortions (trend chi square = 5.67, p
= 0.017) and low birth weight (trend chi square = 9.3, p
= 0.003) with increase in fructosamine levels. A similar
increase in abortion and low birth weight prevalence
rates  were also observed with increase in HbA1c but
the trend did not reach statistical significance [Fig. 2].
DISCUSSION
Epidemiological studies comparing diabetic and non-
diabetic mothers have very clearly demonstrated adverse
outcomes in diabetic mothers.2,12,14 Further, perinatal
mortality and neonatal mortality rates are markedly
higher among diabetic, compared to non-diabetic,
pregnancies. A study conducted in Norwich showed
that perinatal mortality rate in diabetic pregnancies was
48 per 1000 compared to 8.9 per 1000 in non-diabetics
and neonatal mortality was also higher in diabetic
compared to non-diabetic pregnancies.15
In our study, among the diabetic mothers, proportion
of abortions and assisted deliveries were significantly
higher compared to non-diabetic controls and  this is in
agreement with earlier studies.16 The frequency of low
birth weight babies in non-diabetic controls was 14.3%,
which was slightly higher than that observed in the
diabetic mothers. However, this is lower than the overall
figures reported for  India (28%) by the National Family
Health Survey [NFHS].17 This could probably be due to
inclusion of study subjects from urban Chennai where
people probably belong to higher socio-economic status
compared to the whole of India in the NFHS, which
includes rural areas and also poorer states like Bihar
and Orissa.  It may also be due to the small sample size.
The lower prevalence of low birth weight among the
diabetic subjects may be a reflection of higher frequency
of macrosomia produced by diabetes. This is further
substantiated by the higher prevalence of large babies
among the diabetic mothers (Table 2).
Pregnancy outcomes in diabetic women have
improved dramatically over years with temporal trends
showing a decline in rates of spontaneous abortions in
diabetic mothers.16 However, diabetic mothers still carry
a higher risk for fetal morbidity and mortality. A recent
prospective study has shown that inspite of planned
pregnancies with good glycemic control, diabetic
mothers still had higher rates of maternal and perinatal
complications.18 One study from Kolkata also showed
that tight diabetes control was not the only factor
influencing pregnancy outcomes.5
Though there are studies in Asian Indians on the
prevalence of PGDM and GDM among pregnant
mothers,6,16 there have been very few studies comparing
the outcomes in these two groups.5 In this study, we
compared the pregnancy outcomes in mothers with
PGDM and GDM. The prevalence of abortions in the
GDM group in this study was 2.7% compared to 10.1%
in the PGDM group showing that PGDM are at increased
risk for abortions. Other studies have also demonstrated
higher rates of abnormalities in pregnancy outcomes in
PGDM compared to GDM.5,18 This is explained by the
fact that patients with PGDM generally tend to have
more severe diabetes. Moreover, the PGDM group
included patients with Type 1 diabetes. It is well known
that Type 1 diabetes complicating pregnancy is
associated with worse prognosis because of the severity
of the condition.19
The proportion of abortions observed in PGDMs
(10.1%) in this study is comparable to that reported in
other studies.16,20 Among GDMs 2.7% of the mothers had
abortions, which is in contrast to an earlier study in
India, which showed that there were no abortions among
GDMs.7 This is probably a reflection of the referral
Fig. 1 : Proportion of low birth weight babies and abortions in
relation to fructosamine levels.
Fig.2 : Proportion of low birth weight babies and abortions in
relation to HbA1c levels.
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patterns at different centres. It is well known that blood
glucose control as shown by fructosamine or  HbA1c
levels at the time of conception, is an important
determinant of the outcome of the pregnancy. It is likely
that the patients were referred to our centre at a later
stage by obstetricians and this could adversely influence
the outcomes.
The GDM women had a slightly higher frequency of
large babies compared to PGDM mothers. This is
consistent with earlier studies.18 The reason could
probably due to insulin resistance as shown by
decreased insulin binding and associated metabolic
abnormalities, which is more pronounced in GDM than
in PGDM.6 An earlier study had shown that even women
with impaired glucose tolerance had higher rates of large
babies compared to normals.14
Congenital anomalies were more common in the
PGDM group than the GDM group although this was
not statistically significant. This is comparable to earlier
studies.5,18
One of the interesting,  but expected observations in
this study, is that abortions and occurrence of low birth
weight among babies showed a linear relationship with
poor glycemic control as estimated by fructosamine. Poor
glycaemic control has been shown to be associated with
low birth weight babies, increased incidence of
congenital anomalies, spontaneous abortions, perinatal
morbidity and mortality and caesarean sections.
Thus the present study indicates the importance of
tight glycemic control during pregnancy. Tight glycemic
control has been shown to reduce both maternal and
fetal complications.21 This underscores the fact that pre-
conceptional screening for diabetes has to be given high
priority in high-risk women and tight control of diabetes
must be achieved even before conception in those with
PGDM.
In conclusion, women with PGDM are at greater risk
of unfavorable pregnancy outcomes than GDM.
Pregnancy outcomes also depend on glycemic control
and hence tight control of diabetes must be attempted
right through the pregnancy, probably starting even
before the time of conception through combined pre-
pregnancy  diabetic clinics, jointly run by diabetologists
and obstetricians.
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